Skip to main content
Premium Trial:

Request an Annual Quote

Quantum-Si Acquires Semiconductor Firm Majelac Technologies

NEW YORK – Proteomics firm Quantum-Si said Tuesday that it has acquired semiconductor company Majelac Technologies.

Quantum-Si said the acquisition secured Garnet Valley, Pennsylvania-based Majelac's semiconductor chip assembly and packaging capabilities and would help bolster the supply chain for its chip-based biosensing platform and support its commercialization efforts.

Founded by Jonathan Rothberg, who also founded next-generation sequencing company Ion Torrent, Guilford, Connecticut-based Quantum-Si aims to similarly apply semiconductor chip technology to protein sequencing, allowing for single-molecule analysis of proteins, including post-translational modifications. Ultimately, the company plans to apply its technology to molecules other than proteins, including metabolites and nucleic acids.

"The acquisition of Majelac brings chip assembly and packaging capabilities in-house, and it also accelerates our ability to scale up operations to meet demand and support future chip designs," Quantum-Si CEO John Stark said in a statement. "This strategic acquisition and vertical integration allow us to secure our supply chain to meet customer demand amidst existing global semiconductor supply chain issues."

Financial and other terms of the acquisition were not disclosed.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.